Document is current
Any future updates will be listed below
-
Authors
Decanter, Christine
Dassonneville, Audrey
D’Orazio, Emmanuelle
Behal, Hélène
Gagez, Anne-Laure
Mailliez, Audrey https://orcid.org/0000-0002-0475-8631
Pigny, Pascal https://orcid.org/0000-0003-3926-4487
-
Funding
Funding for this research was provided by:
GCS Alliance Cancer (GCS 2022-AM-PP, ONCO AMH1 project, GCS 2022-AM-PP, ONCO AMH1 project)
Centre Hospitalier Universitaire de Lille
- License Information
-
More Information
Article History
Received: 9 December 2024
Accepted: 31 March 2025
First Online: 12 April 2025
Declarations
:
: ONCOAMH1 study has been reviewed and approved by the Commission for Clinical Studies of the Centre Oscar Lambret (Lille, France) under the reference CEC- 2023–022. This study complies with the Reference Methodology MR004 of the CNIL (Commission Nationale de l’Informatique & des Libertés, Paris, France).
: The authors declare no competing interests.
